Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...

High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

"It was important to conduct a large randomized controlled trial to evaluate the efficacy of high-dose cholecalciferol as ...

DAVID MAILAND is a Door County Multiple Sclerosis Alliance peer leader I was diagnosed with Multiple Sclerosis on Dec. 26, ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare ...

Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who ...

Proposed McDonald criteria revisions could help diagnose MS patients who would have been missed with earlier versions, an ...